There were previous studies that 68Ga-PSMA PET/CT could be reliably used to detect prostate cancer because it could clearly show the lesion boundaries.27,28 However, the relatively short half-life of 68Ga and the high energy of positron make 18F-labeled radioactive tracers more widely used. This evidence concerns the gene FOLH1 and prostate cancer.